Nasserinejad Maryam, Shojaee Sadjad, Ghobakhlou Mehdi, Lak Elena, Eslami Pegah, Pourhoseingholi Mohamad Amin
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Clinical Research Development Unit, Shahid Beheshti Hospital, Hamadan University of Medical Sciences, Hamadan, Iran.
Gastroenterol Hepatol Bed Bench. 2019;12(Suppl1):S117-S122.
The present study aimed to evaluate the association between serum levels of interleukin IL-1, IL-6, IL-8 genes as well as interferon (IFN)-γ and the risk of celiac disease (CD).
The role of serum cytokine levels in the pathophysiology of CD is still an open field to be explored.
This case-control study was performed on 110 patients with CD and 46 healthy controls referring to Taleghani Hospital, Tehran, Iran. Expression levels of IL-1, IL-6, IL-8, and IFN-γ were assessed by enzyme-linked immunosorbent assay (ELISA) kits.
The Bayesian intervention odds ratio (OR) and Highest Posterior Density (HPD) interval were 1.133 (95% credible interval 1.018- 1.269), 0.947 (95% credible interval 0.898 - 0.996) and 1.004 (95% credible interval 1.001- 1.009) for IL-1, IL-6, and IL-8 respectively.
The serum level of IFN-γ has no effect on the risk of CD, but given the OR and the HPD interval obtained for serum levels of IL-1, IL-6 and IL-8, with one unit increase in IL-1 serum, the risk of CD grows by 1.13 times while one unit increase in IL-6 serum reduces the risk of CD by 15%. Finally, regarding IL-8, the risk of CD increases by 0.004 times with a unit increase in IL-8 serum.
本研究旨在评估白细胞介素IL-1、IL-6、IL-8基因以及干扰素(IFN)-γ的血清水平与乳糜泻(CD)风险之间的关联。
血清细胞因子水平在CD病理生理学中的作用仍是一个有待探索的领域。
本病例对照研究对转诊至伊朗德黑兰塔莱加尼医院的110例CD患者和46例健康对照进行。采用酶联免疫吸附测定(ELISA)试剂盒评估IL-1、IL-6、IL-8和IFN-γ的表达水平。
IL-1、IL-6和IL-8的贝叶斯干预优势比(OR)和最高后验密度(HPD)区间分别为1.133(95%可信区间1.018 - 1.269)、0.947(95%可信区间0.898 - 0.996)和1.004(95%可信区间1.001 - 1.009)。
IFN-γ的血清水平对CD风险无影响,但考虑到IL-1、IL-6和IL-8血清水平的OR和HPD区间,IL-1血清水平每增加一个单位,CD风险增加1.13倍,而IL-6血清水平每增加一个单位,CD风险降低15%。最后,关于IL-8,IL-8血清水平每增加一个单位,CD风险增加0.004倍。